Placeholder text

Go to cart

Transplantation in Hematology and Oncology II

By Berdel, W. E.

Transplantation in Hematology and Oncology II Medicine

Transplantation in Hematology and Oncology II

0 - Default Title
Description
Cellular Therapy: Targets and Effectors.- Adoptive Immunotherapy in Chimeras.- The Roles of the Chemokine SDF-1 and its Receptor CXCR4 in Human Stem Cell Migration and Repopulation of NOD/SCID and B2mnull NOD/SCID mice.- Towards Adoptive Immunotherapy Using High Affinity T Cell Receptors.- New Antigens and Avenues to Immunotherapy of Cancer.- Allogeneic Cell Therapy with Antigen-Specific Cytotoxic T Lymphocytes (CTL) for Malignant Melanoma.- New Conditioning Strategies n Allogeneic Stem Cell Transplantation.- Intensification of the Conditioning Regimen for Patients with high-risk AML and MDS: 3 year Experience of using an188 Re - Labelled anti - CD 66 Monoclonal Antibody.- Dose Reduced Conditioning for Allogeneic Blood Stem Cell Transplantation from Sibling and Unrelated Donors in 51 Patients.- Pharmacokinetics of Conditioning Regimens.- Megadose Stem Cell Transplantation.- HD-Ara-C in the Conditioning Regimen for BMT in Acute Leukemias.- TBI-Based Reduced Intensity Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation (SCT) in Patients with High-Risk Hematologic Malignancies.- Total Marrow Irradation (TMI), Busulfan, and Cyclophos-phamide for Allografting in Multiple Myeloma. A Pilot Study.- Stem Cell Mobilisation, Processing and Characteristics.- A "Single" Delayed Application of G-CSF after Autologous Peripheral Blood Stem Cell Transplantation - A Pilot Study.- Factors Influencing PBPC Mobilisation and Collection in Haematological Malignancies.- Successful Purging of Stem Cell Products Using CD34 Selection.- Autologous Transplantation of Non-Cryopreserved HSCs in Oncologic Patients with Poor Prognosis: First Experience in the Ukraine.- A Randomized Comparison of Once Versus Twice Daily rhG-CSF (Filgrastim) for Stem Cell Mobilisation inHealthy Donors for Allogeneic Transplantation.- CD 133/CD34 Expression on Hematopoietic Stem-/ Progenitor Cells and Acute Leukemic Blasts.- Identification of Minimal Residual Leukemia Applying Continuous Gating.- Cord Blood Transplantation.- Pilot Study - Lymphocyte Subset Reconstitution after Cord Blood Transplantation.- Altered Growth Characteristics of Cord Blood after in vivo Exposure of the Mother to Chemotherapy.- Mismatched Donor Transplantation.- Bone Marrow Transplantation from Mismatched Unrelated Donors.- Immune Reconstitution after Haploidentical Stem Cell Transplantation.- Clinical Transplantation - Hematologic Malignancies.- Autografting and Allografting for Chronic Lymphocytic Leukemia: Is there a Rationale?.- Results of Stem Cell Transplantation in Children with CML in Comparison with Treatment with Cytostatics alone or with Interferon alfa. Report of the Polish Children's Leukemia/Lymphoma Study Group.- Comparison of Allogeneic Matched Related Stem Cell Transplantation in 1st CR with Chemotherapy alone in Children with High-Risk AML.- Stem Cell Transplantation in Acute Myeloid Leukemia after Conditioning with Busulfan, Cyclophosphamide and Different Dosages of Etoposide (VP-16).- The Occurrence of Acute Graft-Versus-Host Disease and Infectious Complications in Patients with Acute and Chronic Myeloid Leukemia who Underwent Allogeneic Peripheral Blood Stem Cell Transplantation.- Long-Term Survival after Stem Cell Transplant in Adult Acute Lymphoblastic Leukemia.- Clinical Transplantation - Solid Tumors.- Autologous Transplantation in Breast Cancer in Europe and EBMT Data.- First-Line and Salvage High-Dose Chemotherapy in Patients with Germ-Cell Tumors.- High Dose Chemotherapy in High-Risk Ewing Tumours: Results in 156 (EI)CESS Patients.- RapidSequence Tandem Transplant in Children with High-Risk Neuroblastoma.- Anti-Angiogenesis.- Angiogenesis Inhibitor TNP-470 During Bone Marrow Transplant and in Minimal Residual Disease.- Challenges in the Treatment of Fungal Infections.- Prophylaxis of Fungal Infections in Neutropenic Patients with Hematologic Malignancies.
Product details
Edition:
1
Number of Pages:
328
Release Date:
2002-09-19
Publication Date:
2002-09-19
Publisher:
Springer
Languages:
Original: English
ISBN10:
3540421556
ISBN13:
9783540421559
GPSR Manufacturer Reference:
[email protected]
Weight:
658 g
Height:
160 cm
Width:
241 cm
Thickness:
23 cm
Buy on Amazon
Currently sold out